Defining EMS and ENU dose–response relationships using the Pig-a mutation assay in ratsKrista L. Dobo, Maik Schuler, Ronald D. Fiedler et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2011Cited by 48
Report on stage III <i>Pig‐a</i> mutation assays using <i>N</i>‐ethyl‐<i>N</i>‐nitrosourea – comparison with other in vivo genotoxicity endpointsZoryana Cammerer, Maik Schuler, Donna Dickinson et al.|Environmental and Molecular Mutagenesis|2011Cited by 40
Development and validation of an in vitro micronucleus assay platform in TK6 cellsZhanna Sobol, Maik Schuler, Michael L. Homiski et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2012Cited by 39
Evaluation of the nitrosamine impurities of <scp>ACE</scp> inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potentialJennifer Cheung, Maik Schuler, Shaofei Zhang et al.|Environmental and Molecular Mutagenesis|2024Cited by 14
N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 DaJoel P. Bercu, Mike W Urquhart, Olivier Dirat et al.|Regulatory Toxicology and Pharmacology|2024Cited by 14